1-5 of 5
Saheli Sarkar, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptomic and Metabolomic Profiling Identifies Calcium-Dependent Signaling Mechanisms As a Novel and Exploitable Target to Overcome Anti-CD20 Resistance in Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Saheli Sarkar, PhD, Afshin Beheshti, PhD, Maisarah Mokhtar, B.S, Tali Konry, PhD, Michael Levin, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 1511.
https://doi.org/10.1182/blood-2019-126539
Published: 2019
Journal Articles

Systems Biology Analyses to Delineate Mechanisms of Anti-CD20 Antibody Resistance in Non-Hodgkin Lymphoma (NHL): Influence of BCR Signaling and the Critical Importance of Calcium Polarization

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Saheli Sarkar, PhD, Tali Konry, PhD, Michael Levin, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1665.
https://doi.org/10.1182/blood-2018-99-118787
Published: 2018
Journal Articles

Harnessing Microfluidic Single Cell (MF-SC) and 3D "Organ-on-Chip" Assay Technologies for the Investigation of Immunotherapy and Study of Tumor Microenvironment (TME) in Antibody-Resistant Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Saheli Sarkar, PhD, Pooja Sabachandani, MS, Sneha Purvey, MD, Afshin Beheshti, PhD, Tali Konry, PhD, Andrew M Evens, DO,MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 1473.
https://doi.org/10.1182/blood.V130.Suppl_1.1473.1473
Published: 2017
Journal Articles

CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel "Off the Shelf" Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and a Human Lymphoma Xenograft Model

Sneha Purvey, MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Andreas Klein, MD, Laurent Boissel, PhD, Saheli Sarkar, PhD, Tali Konry, PhD, Andrew M Evens, DO,MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 110.
https://doi.org/10.1182/blood.V130.Suppl_1.110.110
Published: 2017
Journal Articles

CD19 Target Activated Natural Killer (CD19.TaNK) Cellular Therapy: A Novel immunotherapeutic Approach to the Treatment of Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Saheli Sarkar, PhD, Pooja Sabhachandani, Frank C. Passero, Jr., MD, Sneha Purvey, MD, Laurent Boissel, PhD, Tania Konry, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 4174.
https://doi.org/10.1182/blood.V128.22.4174.4174
Published: 2016